StonvexLoading…
StonvexStonvexStonvexCore line items from DHI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $9.25B | $14.45B | $6.89B | $34.25B | $24.57B |
Operating Income | Not available | $1.67B | $798.10M | $4.74B | $3.54B |
Net Income | Not available | $1.24B | $594.80M | $3.59B | $2.68B |
EPS (Diluted) | $3.02 | $4.27 | $2.03 | $11.57 | $8.53 |
Total Assets | Not available | $35.57B | $34.64B | $35.47B | $36.40B |
Total Liabilities | Not available | $11.37B | $10.08B | $10.73B | $11.80B |
Cash & Equivalents | Not available | $1.92B | $2.51B | $2.99B | $2.61B |
Free Cash Flow OCF − CapEx | Not available | $376.90M | $826.60M | $3.28B | $855.50M |
Shares Outstanding | Not available | 284.94M | 290.50M | 294.48M | 298.95M |